Elsevier

Regulatory Peptides

Volume 129, Issues 1–3, 15 July 2005, Pages 139-146
Regulatory Peptides

Pituitary adenylate cyclase-activating polypeptide: Localization and differential influence on isolated hearts from rats and guinea pigs

https://doi.org/10.1016/j.regpep.2005.02.012Get rights and content

Abstract

This study was done to determine if pituitary adenylate cyclase-activating peptide (PACAP)-immunoreactive nerve fibers occur in cardiac muscle as well as intracardiac ganglia of rats and guinea pigs and to clarify the chronotropic actions of PACAP27 in the same species using isolated heart preparations. PACAP nerve fibers were not detected in atrial or ventricular muscle of rat or guinea pig but a few stained nerve fibers occurred in the atrioventricular bundle of the guinea pig. Stained nerve fibers were prominent in intracardiac ganglia of both species. PACAP27 caused a dose-dependent tachycardia in isolated rat hearts (+39 ± 3 beats/min with 1 nmol, n = 6). Positive and/or negative chronotropic responses were evoked by PACAP27 in guinea pig heart, depending on dose and prior exposure to the peptide. PACAP27 also caused arrhythmias in several guinea pig hearts. Treatment with atropine eliminated or prevented PACAP-evoked bradycardia and arrhythmias, implicating cholinergic neurons in these responses. Positive chronotropic responses to PACAP were unaffected by beta-adrenergic receptor blockade in either species, suggesting that tachycardia resulted from a direct action on the heart. These observations support the conclusion that endogenous PACAP could have a role in regulating parasympathetic input to the heart but through different mechanisms in rats versus guinea pigs. A direct positive chronotropic influence of endogenous PACAP is unlikely since atrial muscle lacks PACAP-immunoreactive nerve fibers.

Introduction

Pituitary adenylate cyclase-activating polypeptide (PACAP) was first isolated from ovine hypothalamus and subsequently identified in neurons and nerve fibers at various sites within the central and peripheral nervous system [1]. Full-length PACAP (PACAP38) and a shorter form (PACAP27) are derived from a single precursor and have similar biological actions and potencies. Vasoactive intestinal polypeptide (VIP) belongs to the same peptide family as PACAP and has about 68% sequence homology with PACAP27. Some overlap in the pharmacological profiles of these peptides exists due to the fact that VIP and both forms of PACAP have high and comparable affinities for VPAC1 and VPAC2 receptors [1], [2]. PACAP27 and PACAP38 can also have unique effects through high affinity binding to PAC1 receptors, which have only low affinity interactions with VIP [1]. Both anatomical and functional studies have provided evidence that VIP could have a role in local neuroregulation of the heart [3], [4]. Recent investigations have shown that PACAP likewise has potent pharmacological effects on the heart and exhibits some distinct effects compared to VIP [1], [5], [6].

The influence of PACAP on cardiac function has been studied most thoroughly in canine models where the peptide causes biphasic changes in heart rate, conduction velocity and atrial contractility [6], [7], [8], [9], [10]. Cholinergic neurons mediate the inhibitory responses to PACAP27 and PACAP38 in isolated canine heart preparations whereas the excitatory actions of PACAP occur as direct effects on cardiac tissue. Studies with isolated atrial ganglia from guinea pigs have shown that PACAP stimulates intracardiac cholinergic neurons in this species as well through a direct effect on neuronal cell bodies [11]. Application of PACAP to these cells increased their excitability and frequently evoked action potentials. The same investigators demonstrated that PACAP is localized to preganglionic cholinergic nerve fibers that innervate the intracardiac ganglia suggesting that PACAP could have a physiological role in regulation of parasympathetic input to the guinea pig heart [12]. In accord with these observations, functional studies with spontaneously beating atria from guinea pigs have demonstrated that PACAP but not VIP causes bradycardia mediated by cholinergic neurons [5]. However, a significant number of the atria in that study did not respond to PACAP and neither peptide evoked a positive chronotropic response. Cholinergic nerves that innervate rat intracardiac ganglia also contain PACAP [13] but application of the peptide to these cells has not been reported to evoke action potentials [14], [15]. Furthermore, experiments with spontaneously beating rat atria have not demonstrated a negative chronotropic response to PACAP [5], [16], although a small magnitude of tachycardia was noted in one report [5]. Positive chronotropic responses to VIP have been well documented in experiments with isolated perfused hearts from guinea pigs and rats [17], [18].

The present study was initiated to determine if PACAP-immunoreactive nerve fibers occur in cardiac muscle as well as intracardiac ganglia of rats and guinea pigs and to clarify the chronotropic responses evoked by PACAP27 in isolated perfused hearts from the same species. PACAP immunoreactivity was identified in tissue sections by immunohistochemistry using the avidin biotinylated enzyme complex method. Functional studies were done using non-working hearts perfused at a constant rate with physiological buffer.

Section snippets

Tissue preparation for immunohistochemistry

Sprague–Dawley rats (200–250 g) of either sex or male Hartley guinea pigs (300–400 g) were pretreated with heparin (500 units/kg, i.p.) 15–20 min before they were anesthetized using sodium pentobarbital (70 mg/kg, i.p.). Deeply anesthetized animals were perfused transcardially with 0.1 M phosphate buffered saline (PBS, pH 7.4) followed by 4% paraformaldehyde in PBS. Hearts were removed and postfixed overnight at 4 °C. For some experiments, the initial fixation was accomplished by in vitro

PACAP immunoreactivity in rat and guinea pig hearts

PACAP-immunoreactive nerve fibers were observed in intracardiac ganglia of rats and guinea pigs (Fig. 1A and B). This labeling occurred primarily as punctate staining around the cell body of principal neurons and occasionally as swellings along stained nerve fibers. Many intracardiac neurons from both species had PACAP-immunoreactive nerve fibers in close proximity. PACAP-immunoreactive nerve fibers were not detected in atrial or ventricular tissue from rats. A few stained nerve fibers were

Discussion

Our findings demonstrate that PACAP innervation of rat and guinea pig hearts is restricted essentially to the intracardiac parasympathetic ganglia. However, isolated hearts from these species differ in their responses to exogenous PACAP; a modest tachycardia occurs with rat hearts whereas biphasic chronotropic responses occur with the guinea pig. Negative chronotropic responses in the guinea pig were blocked by atropine, indicating that they are mediated by cholinergic neurons. Tachycardia was

Acknowledgements

This study was supported by NIH grant HL54633.

References (33)

  • Y. Suzuki et al.

    Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the cardiovascular system

    Regul Pept

    (1993)
  • J. Christophe et al.

    Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology

    Peptides

    (1984)
  • L.L. Frase et al.

    Cardiovascular effects of vasoactive intestinal peptide in healthy subjects

    Am J Cardiol

    (1987)
  • W.I. DeHaven et al.

    Heterogeneity of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide receptors in rat intrinsic cardiac neurons

    Neurosci Lett

    (2002)
  • D. Vaudry et al.

    Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions

    Pharmacol Rev

    (2000)
  • M. Laburthe et al.

    VPAC receptors for VIP and PACAP

    Recept. Channels

    (2002)
  • Cited by (15)

    • New insights about the peculiar role of the 28–38 C-terminal segment and some selected residues in PACAP for signaling and neuroprotection

      2018, Biochemical Pharmacology
      Citation Excerpt :

      On the one hand, PAC1 is widely distributed in the central nervous system and its activation by both PACAP isoforms produce antiapoptotic actions. On the other hand, triggering VPAC1 induces anti-inflammatory processes [11,46], whereas VPAC2 stimulation mostly leads to peripheral effects such as vasodilation and tachycardia that could be detrimental in the context of chronic treatment [9,58]. Various studies have been carried out to develop selective PAC1 ligands but to date, only PAC1/VPAC1 selective peptides have been obtained [12,28].

    • PAC<inf>1</inf> receptors mediate positive chronotropic responses to PACAP-27 and VIP in isolated mouse atria

      2013, European Journal of Pharmacology
      Citation Excerpt :

      Tachycardia can occur in vivo as a reflex response to the primary vasodilator effect of these peptides, but PACAP can also evoked tachycardia by stimulating PAC1 receptors at sympathetic ganglia (Vaudry et al., 2009). Work with isolated hearts from dogs, guinea pigs, and rats further demonstrated that PACAP and VIP increase heart rate by a direct effect on the atrial myocardium (Hoover, 1989; Henning and Sawmiller, 2001; Chang et al., 2005). All three PACAP/VIP receptors are expressed in atrial and ventricular myocardium of the rat and human (Baron et al., 2001; Saetrum Opgaard et al., 2001), but definitive evidence implicating a specific receptor (s) in the positive chronotropic response to PACAP and VIP is lacking.

    • Regulation of neuronal pituitary adenylate cyclase-activating polypeptide expression during culture of guinea-pig cardiac ganglia

      2007, Neuroscience
      Citation Excerpt :

      PACAP facilitates the parasympathetic inhibitory drive to cardiac tissues by increasing cardiac neuron excitability and enhancing acetylcholine release (Seebeck et al., 1996; Chang et al., 2005). In addition, PACAP can also act directly on cardiac tissues to induce tachycardia and arrhythmias (Chang et al., 2005). If under in vivo situations, injured cardiac neurons produce and secrete PACAP onto cardiac tissues, then this could potentially change the normal inhibitory output of the cardiac neurons to a mixed inhibitory/excitatory influence on pacemaker tissue promoting aberrant electrical activity.

    View all citing articles on Scopus
    View full text